Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

I. Blanco, K. Kuchenbaecker, D. Cuadras, X. Wang, D. Barrowdale, GR. de Garibay, P. Librado, A. Sánchez-Gracia, J. Rozas, N. Bonifaci, L. McGuffog, VS. Pankratz, A. Islam, F. Mateo, A. Berenguer, A. Petit, I. Català, J. Brunet, L. Feliubadaló, E....

. 2015 ; 10 (4) : e0120020. [pub] 20150401

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000185

While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04-1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03-1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted pinteraction values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.

Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics The University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania United States of America

Abramson Cancer Center and Department of Medicine The University of Pennsylvania School of Medicine Philadelphia Pennsylvania United States of America

All Wales Medical Genetics Service Glan Clwyd Hospital Rhyl United Kingdom

All Wales Medical Genetics Services Singleton Hospital Swansea United Kingdom

Breast Cancer and Systems Biology Unit Catalan Institute of Oncology L'Hospitalet del Llobregat Catalonia Spain

Cancer Epigenetics and Biology Program IDIBELL L'Hospitalet del Llobregat Catalonia Spain

Cancer Genetics Laboratory Department of Genetics University of Pretoria Arcadia South Africa

Cancer Genomics Laboratory Centre Hospitalier Universitaire de Québec Research Center and Laval University Quebec City Canada

Catalan Institution for Research and Advanced Studies Barcelona Catalonia Spain

Center for Cancer Genetics and Prevention Dana Farber Cancer Institute Harvard Medical School Boston Massachusetts United States of America

Center for Genomic Medicine Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Center for Individualized Medicine Mayo Clinic Scottsdale Arizona United States of America

Center for Medical Genetics Ghent University Ghent Belgium

Central Connecticut Cancer Consortium Hartford Hospital Helen and Harry Gray Cancer Center Hartford Connecticut United States of America

Centre François Baclesse Caen France

Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology University Hospital of Cologne Cologne Germany

Centre of Familial Breast and Ovarian Cancer Department of Medical Genetics Institute of Human Genetics University Würzburg Würzburg Germany

Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology Carmel Medical Center and B Rappaport Faculty of Medicine Haifa Israel

Clinical Cancer Genetics City of Hope Duarte California United States of America

Clinical Genetics Branch Division of Cancer Epidemiology and Genetics National Cancer Institute Maryland Rockville United States of America

Clinical Genetics Guy's and St Thomas' National Health Service Foundation Trust London United Kingdom

Clinical Genetics Research Laboratory Memorial Sloan Kettering Cancer Center New York New York United States of America

Département d'Oncogénétique Centre Jean Perrin Université de Clermont Ferrand Clermont Ferrand France

Department of Cancer Biology Dana Farber Cancer Institute Boston Massachusetts United States of America

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic

Department of Clinical Genetics Aarhus University Hospital Aarhus Denmark

Department of Clinical Genetics Academic Medical Center Amsterdam The Netherlands

Department of Clinical Genetics East Anglian Regional Genetics Service Addenbrookes Hospital Cambridge United Kingdom

Department of Clinical Genetics Erasmus University Medical Center Rotterdam The Netherlands

Department of Clinical Genetics Fox Chase Cancer Center Philadelphia Pennsylvania United States of America

Department of Clinical Genetics Helsinki University Central Hospital Helsinki Finland

Department of Clinical Genetics Karolinska University Hospital Stockholm Sweden

Department of Clinical Genetics Leiden University Medical Center Leiden The Netherlands

Department of Clinical Genetics Maastricht University Medical Center Maastricht The Netherlands

Department of Clinical Genetics Odense University Hospital Odense Denmark

Department of Clinical Genetics Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Department of Clinical Genetics Vejle Hospital Vejle Denmark

Department of Clinical Genetics Vrije Universiteit University Medical Centre Amsterdam The Netherlands

Department of Dermatology University of Utah School of Medicine Salt Lake City Utah United States of America

Department of Epidemiology Cancer Prevention Institute of California Fremont California United States of America

Department of Epidemiology Columbia University New York New York United States of America

Department of Epidemiology Netherlands Cancer Institute Amsterdam The Netherlands

Department of Experimental Oncology Istituto Europeo di Oncologia Cogentech Cancer Genetic Test Laboratory Milan Italy

Department of Genetic Engineering and Biotechnology University of Dhaka Dhaka Bangladesh

Department of Genetics and Biodiversity Research Institute University of Barcelona Barcelona Catalonia Spain

Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland

Department of Genetics Portuguese Oncology Institute and Biomedical Sciences Institute Porto University Porto Portugal

Department of Genetics University Medical Centre Groningen University of Groningen Groningen Netherlands

Department of Gynecology and Obstetrics and Comprehensive Cancer Center Medical University of Vienna Vienna Austria

Department of Gynecology and Obstetrics Christian Albrechts University of Kiel University Medical Center Schleswig Holstein Kiel Germany

Department of Gynecology and Obstetrics Division of Tumor Genetics Klinikum Rechts der Isar Technical University Munich Munich Germany

Department of Gynecology and Obstetrics Ludwig Maximilian University Munich Munich Germany

Department of Gynecology and Obstetrics University Hospital Carl Gustav Carus Technical University Dresden Dresden Germany

Department of Gynecology and Obstetrics University Hospital Düsseldorf Heinrich Heine University Düsseldorf Düsseldorf Germany

Department of Gynecology and Obstetrics University Hospital Ulm Ulm Germany

Department of Health Sciences Research Mayo Clinic Rochester Minnesota United States of America

Department of Human Genetics and Department of Pathology Radboud university medical center Nijmegen The Netherlands

Department of Human Genetics Leiden University Medical Center Leiden The Netherlands

Department of Laboratory Medicine and Pathology Mayo Clinic Rochester United States of America

Department of Medical Genetics University Medical Center Utrecht Utrecht The Netherlands

Department of Medical Oncology Family Cancer Clinic Erasmus University Medical Center Rotterdam The Netherlands

Department of Medicine and Genetics University of California San Francisco San Francisco California United States of America

Department of Molecular Genetics National Institute of Oncology Budapest Hungary

Department of Molecular Medicine Sapienza University Rome Italy

Department of Obstetrics and Gynecology University of Helsinki and Helsinki University Central Hospital Helsinki Finland

Department of Oncology Karolinska University Hospital Stockholm Sweden

Department of Oncology Lund University Hospital Lund Sweden

Department of Oncology Mayo Clinic Rochester Minnesota United States of America

Department of Oncology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Department of Pathology and Laboratory Medicine University of Kansas Medical Center Kansas City Kansas United States of America

Department of Pathology Landspitali University Hospital and BMC Faculty of Medicine University of Iceland Reykjavik Iceland

Department of Pathology Leiden University Medical Center Leiden The Netherlands

Department of Pathology University Hospital of Bellvitge Bellvitge Institute for Biomedical Research L'Hospitalet del Llobregat Catalonia Spain

Department of Pediatrics Child and Family Research Institute University of British Columbia Vancouver Canada

Department of Physiological Sciences 2 School of Medicine University of Barcelona L'Hospitalet del Llobregat Catalonia Spain

Department of Population Sciences Beckman Research Institute of City of Hope Duarte California United States of America

Department of Tumour Biology Institut Curie Paris France

Departments of Pediatrics and Medicine Columbia University Medical Center New York New York United States of America

Division of Cancer Medicine Peter MacCallum Cancer Centre East Melbourne Victoria Australia

Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston Texas United States of America

Division of Clinical Genetics Department of Clinical and Experimental Medicine Linköping University Linköping Sweden

Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of North Carolina Chapel Hill North Carolina United States of America

Division of Gynecologic Oncology NorthShore University HealthSystem University of Chicago Chicago Illinois United States of America

Division of Gynecologic Oncology Ohio State University Columbus Cancer Council Hilliard Ohio United States of America

Division of Gynecologic Oncology Yale University School of Medicine New Haven Connecticut United States of America

Division of Human Cancer Genetics Departments of Internal Medicine and Molecular Virology Immunology and Medical Genetics Comprehensive Cancer Center The Ohio State University Columbus Ohio United States of America

Epidemiological Study of Familial Breast Cancer Centre for Cancer Genetic Epidemiology Department of Public Health and Primary Care University of Cambridge Strangeways Research Laboratory Cambridge United Kingdom

Family Cancer Clinic Netherlands Cancer Institute Amsterdam The Netherlands

Fondazione Istituto di Oncologia Molecolare Milan Italy

Genetic Medicine Manchester Academic Health Sciences Centre Central Manchester University Hospitals National Health Service Foundation Trust Manchester United Kingdom

Genetic Unit Avicenne Hospital Assitance Publique Hôpitaux de Paris Paris Sud Francilien Hospital Evry Corbeil and University Hospital Clermont Ferrand France

Gynecologic Oncology Group Statistical and Data Center Roswell Park Cancer Institute Buffalo New York United States of America

Hereditary Cancer Program Catalan Institute of Oncology Hospital Josep Trueta Girona Catalonia Spain

Hereditary Cancer Program Catalan Institute of Oncology L'Hospitalet del Llobregat Catalonia Spain

Human Genetics Group Spanish National Cancer Centre and Biomedical Network on Rare Diseases Madrid Spain

Immunology and Molecular Oncology Unit Istituto Oncologico Veneto Padua Italy

Institut National de la Santé et de la Recherche Médicale U830 Institut Curie Paris France

Institut National de la Santé et de la Recherche Médicale UMR5286 Université Lyon 1 Centre de Recherche en Cancérologie de Lyon Lyon France

Institute for Medical Informatics Statistics and Epidemiology University of Leipzig Leipzig Germany

Institute of Cell and Molecular Pathology Hannover Medical School Hannover Germany

Institute of Human Genetics Campus Virchov Klinikum Charite Berlin Berlin Germany

Institute of Human Genetics Christian Albrechts University of Kiel University Medical Center Schleswig Holstein Kiel Germany

Institute of Human Genetics Department of Human Genetics University Hospital Heidelberg Heidelberg Germany

Institute of Human Genetics University of Münster Münster Germany

Laboratoire de Diagnostic Génétique et Service d'Onco Hématologie Hopitaux Universitaire de Strasbourg Centre Hospitalier Régional Universitaire Nouvel Hôpital Civil Strasbourg France

Laboratoire de Génétique Chromosomique Hôtel Dieu Centre Hospitalier Chambéry France

Molecular Diagnostics Laboratory Institute of Radioisotopes and Radiodiagnostic Products National Centre for Scientific Research Demokritos Athens Greece

Molecular Genetics of Breast Cancer German Cancer Research Center Heidelberg Germany

Molecular Oncology Laboratory Hospital Clínico San Carlos San Carlos Research Institute Madrid Spain

N N Petrov Institute of Oncology St Petersburg Russia

North West Thames Regional Genetics Service Kennedy Galton Centre Harrow United Kingdom

Oncogenetics Group Vall d'Hebron Institute of Oncology and Universitat Autònoma de Barcelona Barcelona Catalonia Spain

Oncology Service Hospital de la Santa Creu i Sant Pau Barcelona Catalonia Spain

Queensland Institute of Medical Research Berghofer Medical Research Institute Brisbane Australia

Sackler Faculty of Medicine Tel Aviv University Ramat Aviv Israel

Samuel Lunenfeld Research Institute Mount Sinai Hospital and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada

Section of Molecular Diagnostics Department of Biochemistry Aalborg University Hospital Aalborg Denmark

St Joseph Hospital of Orange Care of City of Hope Clinical Cancer Genetics Community Research Network Duarte California United States of America

Statistics Unit Bellvitge Institute for Biomedical Research L'Hospitalet del Llobregat Catalonia Spain

The Campbell Family Institute for Breast Cancer Research Ontario Cancer Institute University Health Network Toronto Canada

The Institute of Oncology Chaim Sheba Medical Center Ramat Gan Israel

The Susanne Levy Gertner Oncogenetics Unit Institute of Human Genetics Chaim Sheba Medical Center Ramat Gan Israel

Unit of Medical Genetics Department of Preventive and Predictive Medicine Istituto di Ricovero e Cura a Carattere Scientifico Milan Italy

Unit of Molecular Bases of Genetic Risk and Genetic Testing Department of Preventive and Predictive Medicine Istituto di Ricovero e Cura a Carattere Scientifico Milan Italy

Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents Hospices Civils de Lyon Centre Léon Bérard Lyon France

Université Lyon 1 Centre National de la Recherche Scientifique UMR5558 and Unité de Prévention et d'Epidémiologie Génétique Centre Léon Bérard Lyon France

Université Paris Descartes Sorbonne Paris Cité Paris France

Vilnius University Hospital Santariskiu Clinics Hematology Oncology and Transfusion Medicine Center Department of Molecular and Regenerative Medicine State Research Centre Institute for Innovative medicine Vilnius Lithuania

West Midlands Regional Genetics Service Birmingham Women's Hospital Healthcare National Health Service Trust Edgbaston Birmingham United Kingdom

Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute Cedars Sinai Medical Center Los Angeles California United States of America

Women's College Research Institute University of Toronto Toronto Canada

Yorkshire Regional Genetics Service Leeds United Kingdom

000      
00000naa a2200000 a 4500
001      
bmc16000185
003      
CZ-PrNML
005      
20160108120803.0
007      
ta
008      
160108s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0120020 $2 doi
035    __
$a (PubMed)25830658
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Blanco, Ignacio $u Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
245    10
$a Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers / $c I. Blanco, K. Kuchenbaecker, D. Cuadras, X. Wang, D. Barrowdale, GR. de Garibay, P. Librado, A. Sánchez-Gracia, J. Rozas, N. Bonifaci, L. McGuffog, VS. Pankratz, A. Islam, F. Mateo, A. Berenguer, A. Petit, I. Català, J. Brunet, L. Feliubadaló, E. Tornero, J. Benítez, A. Osorio, T. Ramón y Cajal, H. Nevanlinna, K. Aittomäki, BK. Arun, AE. Toland, BY. Karlan, C. Walsh, J. Lester, MH. Greene, PL. Mai, RL. Nussbaum, IL. Andrulis, SM. Domchek, KL. Nathanson, TR. Rebbeck, RB. Barkardottir, A. Jakubowska, J. Lubinski, K. Durda, K. Jaworska-Bieniek, K. Claes, T. Van Maerken, O. Díez, TV. Hansen, L. Jønson, AM. Gerdes, B. Ejlertsen, M. de la Hoya, T. Caldés, AM. Dunning, C. Oliver, E. Fineberg, M. Cook, S. Peock, E. McCann, A. Murray, C. Jacobs, G. Pichert, F. Lalloo, C. Chu, H. Dorkins, J. Paterson, KR. Ong, MR. Teixeira, . , FB. Hogervorst, AH. van der Hout, C. Seynaeve, RB. van der Luijt, MJ. Ligtenberg, P. Devilee, JT. Wijnen, MA. Rookus, HE. Meijers-Heijboer, MJ. Blok, AM. van den Ouweland, CM. Aalfs, GC. Rodriguez, KA. Phillips, M. Piedmonte, SR. Nerenstone, VL. Bae-Jump, DM. O'Malley, ES. Ratner, RK. Schmutzler, B. Wappenschmidt, K. Rhiem, C. Engel, A. Meindl, N. Ditsch, N. Arnold, HJ. Plendl, D. Niederacher, C. Sutter, S. Wang-Gohrke, D. Steinemann, S. Preisler-Adams, K. Kast, R. Varon-Mateeva, A. Gehrig, A. Bojesen, IS. Pedersen, L. Sunde, UB. Jensen, M. Thomassen, TA. Kruse, L. Foretova, P. Peterlongo, L. Bernard, B. Peissel, G. Scuvera, S. Manoukian, P. Radice, L. Ottini, M. Montagna, S. Agata, C. Maugard, J. Simard, P. Soucy, A. Berger, A. Fink-Retter, CF. Singer, C. Rappaport, D. Geschwantler-Kaulich, MK. Tea, G. Pfeiler, . , EM. John, A. Miron, SL. Neuhausen, MB. Terry, WK. Chung, MB. Daly, DE. Goldgar, R. Janavicius, CM. Dorfling, EJ. van Rensburg, F. Fostira, I. Konstantopoulou, J. Garber, AK. Godwin, E. Olah, SA. Narod, G. Rennert, SS. Paluch, Y. Laitman, E. Friedman, . , A. Liljegren, J. Rantala, M. Stenmark-Askmalm, N. Loman, EN. Imyanitov, U. Hamann, . , AB. Spurdle, S. Healey, JN. Weitzel, J. Herzog, D. Margileth, C. Gorrini, M. Esteller, A. Gómez, S. Sayols, E. Vidal, H. Heyn, . , D. Stoppa-Lyonnet, M. Léoné, L. Barjhoux, M. Fassy-Colcombet, A. de Pauw, C. Lasset, SF. Ferrer, L. Castera, P. Berthet, F. Cornelis, YJ. Bignon, F. Damiola, S. Mazoyer, OM. Sinilnikova, CA. Maxwell, J. Vijai, M. Robson, N. Kauff, MJ. Corines, D. Villano, J. Cunningham, A. Lee, N. Lindor, C. Lázaro, DF. Easton, K. Offit, G. Chenevix-Trench, FJ. Couch, AC. Antoniou, MA. Pujana,
520    9_
$a While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04-1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03-1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted pinteraction values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.
650    _2
$a antigeny CD44 $x genetika $7 D018960
650    _2
$a aurora kinasa A $x genetika $7 D064096
650    _2
$a nádory prsu $x enzymologie $x genetika $x patologie $7 D001943
650    _2
$a karcinogeneze $x genetika $7 D063646
650    _2
$a proteiny buněčného cyklu $x genetika $7 D018797
650    _2
$a alfa receptor estrogenů $x metabolismus $7 D047628
650    _2
$a molekulární evoluce $7 D019143
650    _2
$a extracelulární matrix - proteiny $x genetika $7 D016326
650    _2
$a ženské pohlaví $7 D005260
650    12
$a geny BRCA1 $7 D019398
650    12
$a geny BRCA2 $7 D024522
650    _2
$a genetické lokusy $x genetika $7 D056426
650    _2
$a genetická predispozice k nemoci $x genetika $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a pravděpodobnostní funkce $7 D016013
650    _2
$a mléčné žlázy lidské $x metabolismus $7 D042361
650    _2
$a proteiny asociované s mikrotubuly $x genetika $7 D008869
650    12
$a mutace $7 D009154
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a tubulin $x genetika $7 D014404
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Kuchenbaecker, Karoline $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Cuadras, Daniel $u Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Wang, Xianshu $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America.
700    1_
$a Barrowdale, Daniel $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a de Garibay, Gorka Ruiz $u Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Librado, Pablo $u Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
700    1_
$a Sánchez-Gracia, Alejandro $u Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
700    1_
$a Rozas, Julio $u Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
700    1_
$a Bonifaci, Núria $u Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a McGuffog, Lesley $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Pankratz, Vernon S $u Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
700    1_
$a Islam, Abul $u Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh.
700    1_
$a Mateo, Francesca $u Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Berenguer, Antoni $u Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Petit, Anna $u Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Català, Isabel $u Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Brunet, Joan $u Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain.
700    1_
$a Feliubadaló, Lidia $u Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Tornero, Eva $u Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Benítez, Javier $u Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain.
700    1_
$a Osorio, Ana $u Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain.
700    1_
$a Ramón y Cajal, Teresa $u Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain.
700    1_
$a Nevanlinna, Heli $u Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
700    1_
$a Aittomäki, Kristiina $u Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. $7 gn_A_00002741
700    1_
$a Arun, Banu K $u Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. $7 gn_A_00009068
700    1_
$a Toland, Amanda E $u Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
700    1_
$a Karlan, Beth Y $u Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
700    1_
$a Walsh, Christine $u Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
700    1_
$a Lester, Jenny $u Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
700    1_
$a Greene, Mark H $u Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America.
700    1_
$a Mai, Phuong L $u Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America.
700    1_
$a Nussbaum, Robert L $u Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America.
700    1_
$a Andrulis, Irene L $u Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. $7 gn_A_00006753
700    1_
$a Domchek, Susan M $u Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
700    1_
$a Nathanson, Katherine L $u Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
700    1_
$a Rebbeck, Timothy R $u Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
700    1_
$a Barkardottir, Rosa B $u Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
700    1_
$a Jakubowska, Anna $u Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
700    1_
$a Lubinski, Jan $u Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
700    1_
$a Durda, Katarzyna $u Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
700    1_
$a Jaworska-Bieniek, Katarzyna $u Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
700    1_
$a Claes, Kathleen $u Center for Medical Genetics, Ghent University, Ghent, Belgium.
700    1_
$a Van Maerken, Tom $u Center for Medical Genetics, Ghent University, Ghent, Belgium.
700    1_
$a Díez, Orland $u Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
700    1_
$a Hansen, Thomas V $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Jønson, Lars $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Gerdes, Anne-Marie $u Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Ejlertsen, Bent $u Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a de la Hoya, Miguel $u Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain.
700    1_
$a Caldés, Trinidad $u Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain.
700    1_
$a Dunning, Alison M $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Oliver, Clare $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Fineberg, Elena $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Cook, Margaret $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Peock, Susan $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a McCann, Emma $u All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom.
700    1_
$a Murray, Alex $u All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom.
700    1_
$a Jacobs, Chris $u Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
700    1_
$a Pichert, Gabriella $u Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
700    1_
$a Lalloo, Fiona $u Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.
700    1_
$a Chu, Carol $u Yorkshire Regional Genetics Service, Leeds, United Kingdom.
700    1_
$a Dorkins, Huw $u North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom.
700    1_
$a Paterson, Joan $u Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom.
700    1_
$a Ong, Kai-Ren $u West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom.
700    1_
$a Teixeira, Manuel R $u Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
700    1_
$a ,
700    1_
$a Hogervorst, Frans B L $u Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.
700    1_
$a van der Hout, Annemarie H $u Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
700    1_
$a Seynaeve, Caroline $u Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a van der Luijt, Rob B $u Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
700    1_
$a Ligtenberg, Marjolijn J L $u Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
700    1_
$a Devilee, Peter $u Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
700    1_
$a Wijnen, Juul T $u Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
700    1_
$a Rookus, Matti A $u Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
700    1_
$a Meijers-Heijboer, Hanne E J $u Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands.
700    1_
$a Blok, Marinus J $u Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
700    1_
$a van den Ouweland, Ans M W $u Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Aalfs, Cora M $u Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
700    1_
$a Rodriguez, Gustavo C $u Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America.
700    1_
$a Phillips, Kelly-Anne A $u Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
700    1_
$a Piedmonte, Marion $u Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
700    1_
$a Nerenstone, Stacy R $u Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America.
700    1_
$a Bae-Jump, Victoria L $u Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
700    1_
$a O'Malley, David M $u Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America.
700    1_
$a Ratner, Elena S $u Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
700    1_
$a Schmutzler, Rita K $u Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
700    1_
$a Wappenschmidt, Barbara $u Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
700    1_
$a Rhiem, Kerstin $u Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
700    1_
$a Engel, Christoph $u Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
700    1_
$a Meindl, Alfons $u Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
700    1_
$a Ditsch, Nina $u Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany.
700    1_
$a Arnold, Norbert $u Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany.
700    1_
$a Plendl, Hansjoerg J $u Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany.
700    1_
$a Niederacher, Dieter $u Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
700    1_
$a Sutter, Christian $u Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Wang-Gohrke, Shan $u Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
700    1_
$a Steinemann, Doris $u Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
700    1_
$a Preisler-Adams, Sabine $u Institute of Human Genetics, University of Münster, Münster, Germany.
700    1_
$a Kast, Karin $u Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
700    1_
$a Varon-Mateeva, Raymonda $u Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
700    1_
$a Gehrig, Andrea $u Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
700    1_
$a Bojesen, Anders $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
700    1_
$a Pedersen, Inge Sokilde $u Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
700    1_
$a Sunde, Lone $u Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Jensen, Uffe Birk $u Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Thomassen, Mads $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
700    1_
$a Kruse, Torben A $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Peterlongo, Paolo $u Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy.
700    1_
$a Bernard, Loris $u Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
700    1_
$a Peissel, Bernard $u Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
700    1_
$a Scuvera, Giulietta $u Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
700    1_
$a Manoukian, Siranoush $u Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
700    1_
$a Radice, Paolo $u Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
700    1_
$a Ottini, Laura $u Department of Molecular Medicine, "Sapienza" University, Rome, Italy.
700    1_
$a Montagna, Marco $u Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
700    1_
$a Agata, Simona $u Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
700    1_
$a Maugard, Christine $u Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France.
700    1_
$a Simard, Jacques $u Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
700    1_
$a Soucy, Penny $u Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
700    1_
$a Berger, Andreas $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Fink-Retter, Anneliese $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Singer, Christian F $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Rappaport, Christine $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Geschwantler-Kaulich, Daphne $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Tea, Muy-Kheng $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Pfeiler, Georg $u Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a ,
700    1_
$a John, Esther M $u Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America.
700    1_
$a Miron, Alex $u Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
700    1_
$a Neuhausen, Susan L $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
700    1_
$a Terry, Mary Beth $u Department of Epidemiology, Columbia University, New York, New York, United States of America.
700    1_
$a Chung, Wendy K $u Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America.
700    1_
$a Daly, Mary B $u Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
700    1_
$a Goldgar, David E $u Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
700    1_
$a Janavicius, Ramunas $u Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania.
700    1_
$a Dorfling, Cecilia M $u Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
700    1_
$a van Rensburg, Elisabeth J $u Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
700    1_
$a Fostira, Florentia $u Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece.
700    1_
$a Konstantopoulou, Irene $u Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece.
700    1_
$a Garber, Judy $u Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
700    1_
$a Godwin, Andrew K $u Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
700    1_
$a Olah, Edith $u Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
700    1_
$a Narod, Steven A $u Women's College Research Institute, University of Toronto, Toronto, Canada.
700    1_
$a Rennert, Gad $u Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel.
700    1_
$a Paluch, Shani Shimon $u The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel.
700    1_
$a Laitman, Yael $u The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel.
700    1_
$a Friedman, Eitan $u The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
700    1_
$a ,
700    1_
$a Liljegren, Annelie $u Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Rantala, Johanna $u Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Stenmark-Askmalm, Marie $u Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
700    1_
$a Loman, Niklas $u Department of Oncology, Lund University Hospital, Lund, Sweden.
700    1_
$a Imyanitov, Evgeny N $u N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.
700    1_
$a Hamann, Ute $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
700    1_
$a ,
700    1_
$a Spurdle, Amanda B $u Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
700    1_
$a Healey, Sue $u Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
700    1_
$a Weitzel, Jeffrey N $u Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
700    1_
$a Herzog, Josef $u Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
700    1_
$a Margileth, David $u St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America.
700    1_
$a Gorrini, Chiara $u The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada.
700    1_
$a Esteller, Manel $u Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain.
700    1_
$a Gómez, Antonio $u Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Sayols, Sergi $u Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Vidal, Enrique $u Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Heyn, Holger $u Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a ,
700    1_
$a Stoppa-Lyonnet, Dominique $u Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
700    1_
$a Léoné, Melanie $u Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France.
700    1_
$a Barjhoux, Laure $u Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
700    1_
$a Fassy-Colcombet, Marion $u Department of Tumour Biology, Institut Curie, Paris, France.
700    1_
$a de Pauw, Antoine $u Department of Tumour Biology, Institut Curie, Paris, France.
700    1_
$a Lasset, Christine $u Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
700    1_
$a Ferrer, Sandra Fert $u Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France.
700    1_
$a Castera, Laurent $u Department of Tumour Biology, Institut Curie, Paris, France.
700    1_
$a Berthet, Pascaline $u Centre François Baclesse, Caen, France.
700    1_
$a Cornelis, François $u Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France.
700    1_
$a Bignon, Yves-Jean $u Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France.
700    1_
$a Damiola, Francesca $u Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
700    1_
$a Mazoyer, Sylvie $u Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
700    1_
$a Sinilnikova, Olga M $u Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
700    1_
$a Maxwell, Christopher A $u Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada.
700    1_
$a Vijai, Joseph $u Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
700    1_
$a Robson, Mark $u Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
700    1_
$a Kauff, Noah $u Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
700    1_
$a Corines, Marina J $u Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
700    1_
$a Villano, Danylko $u Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
700    1_
$a Cunningham, Julie $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
700    1_
$a Lee, Adam $u Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
700    1_
$a Lindor, Noralane $u Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
700    1_
$a Lázaro, Conxi $u Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
700    1_
$a Easton, Douglas F $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Offit, Kenneth $u Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
700    1_
$a Chenevix-Trench, Georgia $u Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
700    1_
$a Couch, Fergus J $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
700    1_
$a Antoniou, Antonis C $u Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
700    1_
$a Pujana, Miguel Angel $u Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 4 (2015), s. e0120020
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25830658 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20160108120913 $b ABA008
999    __
$a ok $b bmc $g 1102466 $s 924391
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 10 $c 4 $d e0120020 $e 20150401 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...